logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • TerSera Therapeutics LLC drugs

    FiltersReset Filters
    7 results
    • margenza - margetuximab - cmkb injection, solution, concentrate

      (Margetuximab-Cmkb)
      Tersera Therapeutics Llc
    • prialt

      (ziconotide acetate)
      TerSera Therapeutics LLC
      Usage: PRIALT (ziconotide) is indicated for managing severe chronic pain in adults requiring intrathecal therapy, particularly for those intolerant to or unresponsive to other treatments, including systemic analgesics and intrathecal morphine.
    • quzyttir

      (Cetirizine Hydrochloride)
      TerSera Therapeutics LLC
      Usage: QUZYTTIR™ is indicated for the treatment of acute urticaria in adults and children aged 6 months and older. It is not recommended for pediatric patients under 6 years with impaired renal or hepatic function.
    • varubi

      (rolapitant)
      TerSera Therapeutics LLC
      Usage: VARUBI® is indicated for the prevention of delayed nausea and vomiting in adults undergoing emetogenic cancer chemotherapy, in combination with other antiemetic agents. This includes initial and repeat courses of highly emetogenic chemotherapy.
    • xermelo

      (telotristat ethyl)
      TerSera Therapeutics LLC
      Usage: Xermelo is indicated for treating carcinoid syndrome diarrhea in adults who are inadequately controlled by somatostatin analog (SSA) therapy, and is used in combination with SSA therapy.
    • zoladex

      (goserelin)
      TerSera Therapeutics LLC
      Usage: ZOLADEX is indicated for the management of locally confined Stage B2-C prostatic carcinoma (with flutamide), palliative treatment of advanced prostatic carcinoma, management of endometriosis, endometrial thinning prior to ablation, and palliative treatment of advanced breast cancer in pre- and perimenopausal women.
    • zoladex - goserelin implant

      (Goserelin)
      Tersera Therapeutics Llc